The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)

2019 ◽  
Vol 153 (2) ◽  
pp. 312-319
Author(s):  
Ryusuke Murakami ◽  
Noriomi Matsumura ◽  
Hirofumi Michimae ◽  
Hiroshi Tanabe ◽  
Mayu Yunokawa ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
High Grade ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Mesenchymal Transition ◽  
Serous Ovarian Carcinoma ◽  
Dose Dense ◽  
Taxane Chemotherapy

Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

1999 ◽  
Vol 75 (1) ◽  
pp. 10-14 ◽  
Author(s):  
Jonathan S. Berek ◽  
Maurie Markman ◽  
Bette Stonebraker ◽  
Samuel S. Lentz ◽  
Mark D. Adelson ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Phase Ii ◽  
Gynecologic Oncology ◽  
Interferon Α ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document